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Abstract
Persistent organic pollutants (POPs) are resistant to environmental degradation and can cause multitude of health
problems. Cytochrome P450 1A (Cyp1a) is often up-regulated by POPs through the activation of aryl hydrocarbon receptor
(AhR) pathway and is thus usually used as a biomarker for xenobiotics exposure. To develop a convenient in vivo tool to
monitor xenobiotic contamination in the water, we have established GFP transgenic medaka using the inducible cyp1a
promoter, Tg(cyp1a:gfp). Here we tested Tg(cyp1a:gfp) medaka at three different stages, prehatching embryos, newly
hatched fry and adult with 2,3,7,8-tetrachlorodiebnzo-p-dioxin (TCDD), a dioxin. While GFP induction was observed in all
three stages, newly hatched fry were the most sensitive with the lowest observed effective concentration of 0.005 nM or
16.1 ng/L. The highly sensitive organs included the kidney, liver and intestine. With high concentrations of TCDD, several
other organs such as the olfactory pit, tail fin, gills, lateral line neuromast cells and blood vessels also showed GFP
expression. In addition, Tg(cyp1a:gfp) medaka fry also responded to two other AhR agonists, 3-methylcholanthrene and
benzo[a]pyrene, for GFP induction, but no significant GFP induction was observed towards several other chemicals tested,
indicating the specificity of this transgenic line. The GFP inducibility of Tg(cyp1a:gfp) medaka at both fry and adult stages
may be useful for development of high-throughput assays as well as online water monitoring system to detect xenobiotic
toxicity.
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Introduction
Polycyclic aromatic hydrocarbons (PAHs) and dioxins are
persistent organic pollutant (POPs) which are resistant to
environmental degradation and can persist in soils and sediments
for decades or even centuries [1]. They can enter into aquatic
ecosystem through effluent, atmospheric deposition, petroleum
spill, run-off and ground water. With their persistent presence,
POPs can be bioaccumulated and biomagnified in animal and
human tissues through direct contact and food chains, thus
causing health hazards such as carcinogenicity, organs failures and
system dysfunction [2–4]. Since POPs include a variety of
chemical compounds, the toxicities and affinities of POPs can be
highly complicated. Currently it is widely accepted that most of the
effects of POPs are mediated by aryl hydrocarbon receptor (AhR)
pathway [5], which up-regulates Cyp1a enzyme that catalyzes the
oxygenation of PAHs and heterocyclic aromatic amines/amids,
and many other agents [6]. Cyp1a is often used as a specific and
reliable biomarker for PAH contamination. As such, measurement
of ethoxyresorufin-O-deethylase (EROD) activity is commonly
performed to indicate the enzymatic activity of Cyp1a induced
during chemical exposure [7]. Organisms that inhabit the water
bodies, such as fish, are usually sacrificed to obtain their liver tissue
for EROD assay.
In this study, we intended to develop a convenient biological
tool to monitor PAH exposure using medaka fish (Oryzias latipes),
which is a hardy teleost fish and is able to survive in a broad range
of temperature (4uC to 40uC) as well as in a wide salinity range (0–
50% of sea water) [8]. Transgenic fish have long been proposed for
the purpose of biomonitoring aquatic contaminants as water
sentinels [9,10]. In these biomonitoring fish, they have been
genetically modified to respond to contaminants with easily
detectable reporter, based on the principle that certain genes are
inducible by certain chemical contaminants. Currently, there are
already a few stable transgenic fish lines established for detecting
certain classes of pollutants [11–15]. For example, Tg(mvtg1:gfp)
medaka, with its transgene consists of medaka vitellogenin
promoter and GFP reporter gene, was established and has shown
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to induce GFP in the liver of male fish when exposed to estradiol
[13]. Here we have developed a transgenic medaka line,
Tg(cyp1a:gfp) in which GFP is expressed under the inducible cyp1a
promoter, thus providing a convenient assay for easy detection in
situ and in real time for the presence of cyp1a-inducing chemicals.
Here we exposed the transgenic medaka to TCDD, a well studied
congener of dioxin commonly used as reference point for Toxic
Equivalency Factor (TEF) [2], to determine the sensitivity of the
transgenic line as well as the pattern of induced GFP expression.
In addition to TCDD, GFP expression in Tg(cyp1a:gfp) were also
induced by other PAH chemicals such as 3-methylcholanthrene (3-
MC) and benzo[a]pyrene (BaP), but not by other categories of
chemicals such as mercury chloride, 4-nitrophenol, lindane and
bisphenol A, suggesting that GFP induction in Tg(cyp1a:gfp)
medaka is quite specific to TCDD and members of PAH family.
Thus, Tg(cyp1a:gfp) medaka will be another convenient and useful
tool in environmental monitoring.
Materials and Methods
Fish Husbandry
Hd-rR medaka strain was obtained from National BioResource
Project, Japan [16]. Husbandry of medaka fish was according to
Kinoshita et al., 2009 [8]. Staging of medaka embryos and fry was
mainly based on Iwamatsu, 2004 [17]. Generation of Tg(cyp1a:gfp)
[previously named Tg(cyp1a1:gfp)] transgenic medaka has been
described previously [18]. cyp1a was used here because there is
only one copy of cyp1a gene in the medaka genome [19] All
experimental protocols were approved by Institutional Animal
Care and Use Committee (IACUC) of National University of
Singapore (Protocol 079/07).
Toxic Chemical exposure
TCDD, 3-MC and BaP were purchased from Sigma-Aldrich.
All stock solutions were prepared in dimethyl sulfoxide (DMSO)
(Sigma-Aldrich) and stored at 4uC. Hemizygous transgenic
embryos, fry and fish were used in all chemical exposures for
consistency. Five or more fry (1–3 dph [days posthatching]) or
embryos (6–9 hpf [hours postfertilization]) were placed in each
well of a 6–well dish, containing 5 ml of various concentrations of
a testing chemical and incubated at 28uC. Each experiment was
repeated at least three times. For adult treatment, 6 month-old
transgenic fish, 5 male and 5 female per tested concentration, were
used and chemical solutions were changed every other day. The
fish were not fed during the 72-hour chemical exposures. At the
end of the experiment, all fish were examined for GFP expression.
In all the acute exposure experiments, there was no mortality and
no observable abnormality even with the highest concentration of
TCDD (5 nM) after 24 hours of exposure.
Epifluorescence microscopy
GFP expression was observed under an inverted fluorescence
microscope (Axiovert 200 M, Zeiss) equipped with a digital
camera (Axiocam HRc, ZEISS) for capturing GFP fluorescence.
Fry or fish were first anaesthetized by 0.1% 2-phenoxyethanol
(Sigma-Aldrich) and positioned in 3% methylcellulose (Sigma-
Aldrich) for observation. For adult fish, GFP expression was
observed and imaged with a stereomicroscope, Olympus MVX10
with a digital camera.
Whole mount in situ hybridization
Medaka cyp1a cDNA was amplified from nucleotides +1321 to
+1821 with reference to the transcription start site (Ensembl ID:
ENSORLG00000014421) and subcloned into pGEM-T EASY
(Promega, Madison, WI). Digoxigenin riboprobes of cyp1a was
synthesized using DIG RNA labeling kit (Roche). Whole mount in
situ hybridization was performed essentially according to the
protocol described in Kinoshita et al., 2009 [15]. The period of
proteinase K digestion is either 25 min to maintain surface
epithelial integrity or 80 min for better penetration of riboprobes.
After in situ hybridization, embryos were incubated with alkaline
phosphatase-conjugated anti-DIG Fab Fragments (1:7000; Roche)
and were visualized with tetrazolium chloride and 5-bromo-4-
chloro-3-indolyl-phosphate (Roche).
Results
Selection of Tg(cyp1a:gfp) lines for chemical tests
Four Tg(cyp1a:gfp) transgenic founders were initially identified
and all F1transgenic progenies have been demonstrated to respond
to TCDD treatment by inducing GFP expression in the liver,
intestine and kidney [18]. To select a transgenic strain for
monitoring xenobiotics, transgenic F1 adults that produced
transgenic offspring with low or no GFP background and had a
single transgenic insertion were selected, and finally a transgenic
family, Tg(cyp1a:gfp) 4.2, with the most sensitive response to
TCDD and other xenobiotic chemicals was selected. This
transgenic strain, referred as Tg(cyp1a:gfp), was used for all
chemical exposures experiments in this study and has been
maintained for five generations.
Sensitivity and dosage-dependent GFP expression of
Tg(cyp1a:gfp) medaka in response to TCDD
1–3 dph Tg(cyp1a:gfp) medaka fry were exposed to a range of
concentrations of TCDD for 24 hours to determine its sensitivity
to TCDD (Figure 1). No GFP expression was observed in the
vehicle solvent, 0.1% DMSO-treated transgenic fry (Figure 1).
About 7% of the transgenic fry responded to 0.005 nM TCDD
with GFP expression in the liver (Figure 1I), indicating the lowest
observed effective concentration (LOEC) was around 0.005 nM
TCDD. With the increasing concentrations of TCDD, induced
GFP fluorescence became increasingly intensive and appeared in
more tissues/organs. For examples, at 0.05 nM, GFP expression
was observed in the kidney, liver and also gut (Figure 1D) and the
GFP signal became intensified in these three organs at 0.1 nM
(Figure 1E). At 0.5 nM or above, GFP expression could be
observed in several other organs such as olfactory pits, caudal fin,
gills, neuromast cells along the trunk and around the eyes in
majority of the treated transgenic fry (Figure 1F–H, also see
Figure 2F,I,L). Some fry also exhibited weak GFP expression in
blood vessels along the trunk (Figure 2F), myocardium and skin
epithelial cells (Figure 2F,I). Quantitative GFP expression data in
these major expressing organs are summarized in Figure 1I. The
most sensitive organs were the kidney and liver, followed by the
gut (Figure 1I).
Induced GFP expression is consistent with induced
endogenous cyp1a expression
To determine the endogenous cyp1a mRNA expression after
TCDD exposure, we performed whole mount in situ hybridization
with a cyp1a antisense probe in TCDD-treated wild type fry. The
hybridization signal was observed in major internal organs
including the kidney, liver and gut (Figure 2B), similar to the
typical GFP expression pattern induced by TCDD in Tg(cyp1a:gfp)
fry (Figure 2C); in comparison, there was no hybridization signal
detected in these organs in the vehicle control (Figure 2A).
Similarly, whole mount in situ hybridization with sense riboprobes
did not have any staining (Figure S1), thus demonstrating the
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specificity of the cyp1a antisense probes. Under a short proteinase
K digestion treatment where the integrity of the epithelial surface
of in situ hybridization sample was maintained, hybridization
signals were observed in the neuromast cells along the lateral line,
skin, gills and olfactory pits in TCDD-treated fry (Figure 2E,H,K),
but not in the vehicle control (Figure 2D,G,J). These corresponded
to the sites of GFP expression observed in 5.0 nM TCDD treated
transgenic fry (Figure 2F, I, L). Overall, these observations
demonstrated that induced GFP expression in Tg(cyp1a:gfp)
embryos/fry faithfully represent the induced endogenous cyp1a
expression by TCDD treatment at least in these major expressing
organs.
Specificity of Tg(cyp1a:gfp) in response to other types of
chemicals
To investigate the specificity of Tg(cyp1a:gfp) in response to other
types of chemicals, transgenic fry were also exposed to other PAHs
including 3-MC and BaP. Induced GFP fluorescence was observed
in the kidney, liver and gut by BaP treatment (Figure 3B), in
comparison with the lack of GFP expression in the vehicle control
(Figure 3A). The percentages of fry expressing GFP in these three
organs were quite similar in each concentration of BAP (Figure 3D)
[0.25 mM (62.5 mg/l) to 3.96 mM (1000 mg/l)]. In 3-MC treat-
ment, although GFP expression was also observed in the kidney,
liver and gut (Figure 3C), the liver seemed to be the most sensitive
Figure 1. TCDD-induced GFP expression in posthatched Tg(cyp1a:gfp) fry. (A–H) GFP expression in Tg(cyp1a:gfp) fry at different
concentrations of TCDD. 1–3 dph Tg(cyp1a:gfp) fry were exposed to TCDD for 24 hours and photographed for GFP expression under a fluorescence
microscope. Lateral, dorsal, ventral and tail images were taken from the same representative fry from each concentration group. GFP expressing
tissues are pointed by arrowheads. Abbreviations: g, gut; gi, gills; k, kidney; lv, liver; op, olfactory pit. (I) Percentage of fry expressing GFP in specific
organs at different concentrations of TCDD. The scoring organs were based on direct observation GFP fluorescence under a fluorescence microscope.
Error bars represent standard error. n represents the total number of fry used.
doi:10.1371/journal.pone.0064334.g001
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organ, followed closely by kidney. At the lowest dosage, 23.3 nM
(6.25 mg/l), ,50% of the fry had induced GFP expression in the
liver while ,30% of the fry showed GFP expression in the gut and
kidney (Figure 3E). The percentages of fry expressing GFP in the
kidney and liver were higher than those in the gut for higher
concentrations of 3-MC (Figure 3D) [46.6 nM (12.5 mg/l) to
372.7 nM (100 mg/l)]. Unlike TCDD exposure, GFP expression
was not observed in other organs beyond the liver, kidney and gut
for both 3-MC and BAP treatments. We also tested several other
types of chemicals, including mercury chloride, bisphenol A (BPA),
4-nitrophenol and lindane, but there was no induced GFP
expression observed in the transgenic fry, except that a small
number of fry (,20%) showed weak spotty GFP expression in the
liver at the high concentration, 53.9 mM and 71.89 mM of 4-
nitrophenol (Figure S2). Table 1 summarizes the information of
responses of Tg(cyp1a:gfp) to all these chemicals, including TCDD.
Induction of GFP expression in Tg(cyp1a:gfp) embryos
To fully characterize the induction of GFP expression in early
Tg(cyp1a:gfp) embryos, hemizygous transgenic embryos were
exposed to TCDD continuously from ,6 hpf (stage 10 to stage
11). It was apparent that Tg(cyp1a:gfp) embryos were less sensitive
than post-hatching fry in TCDD induction of GFP expression. Up
to 0.05 nM, there was no robust GFP fluorescence induced up to
72 hours of exposure. At 1.0 nM of TCDD, GFP fluorescence was
observed weakly in the epithelial layer of yolk and embryonic body
at 24 hours of exposure (Figure 4A,B). In a few embryos (6/21),
moderate GFP signal was observed in the retina after 24 hours of
exposure (Figure 4B,D) but diminished from 2 dpf (Figure 4F,H).
At 2 dpf (,48 hours of exposure), weak GFP expression persisted
in the epithelial layer of embryonic body and the yolk
(Figure 4E,F). By 3 dpf (,72 hours of exposure), GFP was clearly
expressed in the liver, kidney tubule, gut and olfactory pits
(Figure 4I–L) in all TCDD- treated transgenic embryos. Longer
exposure period gave similar observations to that of 3-dpf embryos
(Figure 4M–P). In comparison, no GFP expression, except for a
transient, faint GFP signal in the mid-brain at 1 dpf (Figure S3),
was observed in the vehicle solvent group at any time of TCDD
treatment (Figure 4Q–T). In summary, weak induction of GFP
expression can be performed in epithelia and yolk within 24 hours
of fertilization, but robust induction of GFP expression occurs only
after the liver is developed at 3 dpf. These observations may
indicate the possible presence of AhR activity in early stages of
embryonic development. However, the pre-hatching embryos are
relatively insensitive to TCDD induction compared to post-
hatching fry, hinting a lower AhR activity in embryos than that in
fry.
Induction of GFP expression in Tg(cyp1a:gfp) adults
To test whether GFP induction could be directly observed from
live adult Tg(cyp1a:gfp) medaka, 6-month-old adult transgenic fish
were treated with three different concentrations (0.1, 0.5 and
2.5 nM) of TCDD for 72 hours. After 24 hours of treatment, 2
male and 2 female Tg(cyp1a:gfp) fish from each of the three TCDD
concentration groups were randomly picked and observed. In all
the fish observed, GFP was expressed in olfactory pits as well as in
the abdomen region corresponding to the kidney, liver and urinary
pore positions (Figure 5A) while no GFP signal was observed in
non-treated control (Figure 5B). After 72 hours of exposure,
increasing GFP fluorescence was observed in the head, body
trunk, skin and brightly in kidney, urinary pores, gills region, lens,
lips and olfactory pit as well as rib cage in all fish from the three
TCDD-treated groups (Figure 5C,E,F) and again there was no
GFP signal observed in untreated control fish (Figure 5D). To
confirm the GFP expressing organs, we dissected all the fish at the
end of the 72-hour exposure in order to view its internal organs. In
both TCDD-treated males (Figure 5G,H) and females (Figure 5I,J),
the liver was found to have the most intensive GFP signal, next by
the gut (Figure 5G,I). The GFP signal was also strong in the head
kidney and kidney tubules (Figure 5H,J). Interestingly, the
abdomen wall that was dissected out did not fluorescence,
indicating that the earlier mentioned GFP signal in the rib cage
was due to the strong signal from the internal organs which
illuminated the rib cage. This observation indicate the feasibility to
use live adult Tg(cyp1a:gfp) fish to develop an in vivo biomonitoring
system for TCDD and related chemicals.
Discussion
Sensitivity of Tg(cyp1a:gfp) medaka
Previously we have generated several Tg(cyp1a:gfp) medaka for
monitoring TCDD and other POPs [18] and the selection of cyp1a
promoter is because cyp1a is the most reliable and robust
responsive genes to TCDD [20,21]. From multiple Tg(cyp1a:gfp)
founders, here we isolated and characterized a highly sensitive
transgenic line, where GFP expression was detected in the liver,
kidney, gut and several other tissues/organs when treated with
TCDD. In addition, this line has the highest sensitivity towards
TCDD among the four Tg(cyp1a:gfp) families that we have
maintained and compared. The LOEC of TCDD to evoke GFP
expression is around 0.005 nM (Figure 1I) in the hemizygous
Figure 2. GFP induction is similar to induced endogenous cyp1a
transcript in TCDD treatment. (A, B, D, E, G, H, J, K) Whole mount in
situ hybridization detection of cyp1a mRNAs in 0.1% DMSO-treated wild
type fry (A, D, G, J) and 5 nM TCDD-treated wild type fry (B, E, H, K). (C, F,
I, L) GFP expression in 5 nM TCDD treated transgenic fry. Interesting
organs are indicated by arrowheads. Abbreviations: bv, blood vessel; ep,
epithelia; g, gut; gi, gills; k, kidney; lv, liver; mc, myocardium; nm,
neuromast cells; op, olfactory pit.
doi:10.1371/journal.pone.0064334.g002
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Tg(cyp1a:gfp) 1–3 dph fry. The TCDD detection limit of the
traditional EROD assay from cell culture is ranged from 2.4 pM
to 1 nM [22,23]. Thus, the LOEC we estimated based on our
transgenic fish assay is quite comparable to the best EROD
sensitivity reported. In comparison, some limitations exist in the
EROD assay. Firstly, unknown chemicals in the sample could act
as Cyp1a enzyme antagonists, potentiators or competitors, thus
affecting the accuracy of the EROD assay [7,24,25]. Secondly,
EROD assay from cell culture studies has shown to decrease at
high concentrations of inducer, presumably due to inhibition of
Cyp1a enzyme activity by the high concentration of inducer
[23,26,27]. Thirdly, external parameters such as temperature, pH,
etc. can also influence the outcome of EROD assay [7,25,28].
Transgenic fish assay can avoid these problems as it monitors
TCDD more directly from the upstream transcriptional activity,
which is controlled by TCDD-AhR interaction. Thus this
Figure 3. GFP induction of Tg(cyp1a:gfp) fry by BAP and 3-MC. (A–C) GFP expression in Tg(cyp1a:gfp) fry in vehicle control 0.1% DMSO (a),
0.25 mM BAP (B) and 23.3 nM 3-MC (C). GFP expressing tissues are pointed by arrowheads. Abbreviations: g, gut; k, kidney; lv, liver. (D, E) Percentages
of fry expressing GFP in specific organs induced by BAP (D) or by 3-MC (E). Error bars represent standard error. n represents the total number of fry
used.
doi:10.1371/journal.pone.0064334.g003
Table 1. Summary of GFP expression induced in Tg(cyp1a:gfp) fry with different chemical exposures.
Chemicals GFP expression Lowest effective concentration
TCDD liver, kidney, gut, olfactory pits, gills, blood vessels,
neuromast cells, skin, caudal fin, myocardium
0.005–0.01 nM
3-MC liver, kidney and gut #23.3 nM
BaP liver, kidney and gut #247.7 nM
4-nitrophenol Spotty GFP expression in liver 35.9–53.9 mM
Bisphenol A No GFP induction Nil
Mercury chloride No GFP induction Nil
Lindane No GFP induction Nil
doi:10.1371/journal.pone.0064334.t001
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transgenic model provide a better in vivo model for more direct
monitoring of these environmental chemicals than EROD assays.
Compared to several cell-based transgenic assays using similar
dioxin responsive elements linked luciferase reporter gene
[22,24,29,30], our transgenic fish assay is less sensitive as it has
been reported in several cell-based assays have the detection limit
from 0.8 pM to 1.0 pM of TCDD. The higher sensitivity of the
transgenic cell cultures could be due to the direct exposure of cells
by the toxicants while transgenic fish have additional physiological
barrier against xenobiotics intake. However, our transgenic fish
represent an authentic in vivo biological model and it is easy to
perform by direct observation of easily scorable GFP fluorescence
in live fry or adult fish. Moreover, the result is instant and the assay
is economical compared to the EROD and transgenic cell-based
assays. As fish naturally inhabit in the water environment, the
transgenic medaka is an ideal model for developing into an online
monitoring systems to report aquatic contamination by TCDD
and similar pollutants.
Specificity of Tg(cyp1a:gfp) medaka
We have further tested Tg(cyp1a:gfp) medaka fry with other
known Cyp1a inducer such as 3-MC and BaP. Different from
TCDD, BaP and 3-MC evoked GFP expression in the kidney,
liver and gut only. TCDD apparently induced the highest and
strongest reaction of Tg(cyp1a:gfp) among the three chemicals and
at a concentration much lower than BaP and 3-MC, consistent
with many previous reports that TCDD has the greatest affinity
for AhR [20,27,31]. Perhaps, the concentrations of BAP and 3-
MC used in this study may not be high enough to warrant GFP
expression in other organs. Other chemicals such as BPA, lindane
and mercury chloride, all of which are unknown to be AhR
ligands, were tested on Tg(cyp1a:gfp) fry and basically there was no
induced GFP expression observed even with their lethal dosage
and longer exposure periods. Only weak GFP induction was
observed in small percentage of fry in high concentrations of 4-
nitrophenol. Thus, these observations demonstrated that cyp1a
promoter based transgenic line is capable of responding specifi-
cally to AhR ligands such as TCDD, BAP and 3-MC. However,
this transgenic line is unable to predict the exact chemical from its
responses.
Although cyp1a transcription is primarily regulated by AhR
pathway, cyp1a expression is also influenced by hormonal factors
such as glucocorticoids, insulin and sex hormones [32]. These
factors may directly and/or indirectly affect the cyp1a expression
by crosstalking with other transcription factors. Furthermore, AhR
pathway was suggested to be involved in other functions such as
immunology and development in addition to the mediation of
Figure 4. GFP induction in Tg(cyp1a:gfp) embryos by TCDD. 6–
9 hpf hemizygous embryos were treated with 1 nM of TCDD or vehicle
solvent control (0.1% DMSO) continuously. Bright field and fluorescence
images of lateral and head views were taken from a representative
embryo at different time points posttreatment: 24 hrs (A–D), 48 hrs (E–
H), 72 hrs (I–L) and 96 hrs (M–P). No induced GFP expression was
observed in the control group during the course of 96 hrs of treatment
(Q–T). Interesting organs are indicated by arrowheads. Abbreviations: g,
gut; k, kidney; lv, liver;op, olfactory pit.
doi:10.1371/journal.pone.0064334.g004
Figure 5. GFP induction of adult Tg(cyp1a:gfp) medaka by
TCDD. (A, B) Lateral views of GFP induction of a representative male
Tg(cyp1a:gfp) fish at 24 hrs after 2.5 nM TCDD exposure (A) in
comparison with an untreated control fish (B). (C, D) Lateral views of
GFP induction of a representative male Tg(cyp1a:gfp) fish at 72 hrs after
2.5 nM TCDD exposure.(C) in comparison with an untreated control fish
(D) (E, F) Dorsal view (E) and ventral view (F) of the same fish from (C).
Tg(cyp1a:gfp) fish in other TCDD concentrations (0.1 nM and 0.5 nM)
displayed similar expression pattern and intensity to those shown here
in (A, C, E, F). (G, H) GFP expression in the internal organs of a TCDD-
treated male transgenic fish. (I, J) GFP expression in the internal organs
of a TCDD-treated female transgenic fish. Lateral view for the liver and
gut is shown in (G, I) and ventral view for the kidney after removal of
internal digestive organs is shown in (H, J). Abbreviations: g, gut; gi,
gills; k, kidney; ln, lens; lp, lips; lv, liver; op, olfactory pit; rc, ribcage; up,
urinary pore.
doi:10.1371/journal.pone.0064334.g005
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biological responses to chemicals and pollutants [33]. It has been
reported that administration of AhR ligands, such as beta-
naphthoflavone, modulates the induction of estrogen-receptor
mediated downstream gene, suggesting that AhR pathway does
crosstalk with estrogen receptor pathway [32,33,34,35]. However,
we observed no obvious difference between the GFP induction of
transgenic adult male and female fish towards TCDD treatment,
suggesting that the sex hormones did not significantly affect the
transgenic responses towards TCDD.
Spatial induction of GFP expression in Tg(cyp1a:gfp)
medaka
A major advantage of Tg(cyp1a:gfp) medaka over cell-based
transgenic models is the direct detection of tissue-distribution of
induced GFP expression. Interestingly, induction of GFP expres-
sion was first observed in the liver, kidney and gut by TCDD
(Figure 1I) as well by BAP and 3-MC (Figure 3D,E). In situ
hybridization (Figure 2B) of TCDD-treated wild type fry
demonstrated similar induction of endogenous cyp1a mRNAs in
the liver, kidney and gut (Figure 2B). Consistent with our
observation, strong immunohistostaining of Cyp1a has also been
observed in the liver, kidney and gut lining after TCDD treatment
in zebrafish as well as in other fish species [25,36]. It is generally
shown that the liver and kidney are major sites of xenobiotic
metabolism and excretion, thus resulting in high level of Cyp1a
activity. Due to dietary exposure, accumulation of xenobiotics
could occur in the gut and induce Cyp1a [25]. However, in our
exposure treatments, the fry were not fed yet but the gut was still a
major organ for induced GFP expression. Thus, it is possible that
gastrointestinal tract also acts as a major organ for detoxification.
Interestingly, in 3-MC treatment, the percentage of fry with GFP
induction in the gut was not as high as those in BAP and TCDD
treatments, signifying differential organ affinity to different
chemicals or differential distribution of different chemicals in
different organs.
In addition to GFP induction in the kidney, liver and gut in
Tg(cyp1a:gfp) fish, GFP was also induced in epithelial surface such
as neuromast cells, olfactory pits, gills and skin. These have been
confirmed by in situ hybridization (Figure 2E,H,K). Noticeably,
neuromast cells, olfactory pits, gills and skins were organs that
were in direct contact with toxicants in water; thus, non-enriched
TCDD may directly interact with the AhR pathway while in the
metabolic organs including the liver, kidney and gut, TCDD could
be enriched and thus achieve higher response. It has also been
reported from several fish studies that Cyp1a is present in olfactory
pits, gills and skins in AhR-ligands treated fishes by immunostain-
ing [25,36]. To our knowledge, our observation that cyp1a gene is
inducible by TCDD in neuromast cells is a novel finding.
Fewer organs showed cyp1a mRNA induction by in situ
hybridization analysis than those displayed induced GFP expres-
sion in Tg(cyp1a:gfp) fish under the same TCDD chemical
treatment. Organs that expressed GFP but not detected by in
situ hybridization include blood vessels along the trunk of the body
(Figure 2F), caudal fin (Figure 1F4,G4,H4) and heart muscles. The
difference between the two assays may reflect a detection
sensitivity rather than ectopic GFP induction in the transgenic
medaka. Consistent with our argument, it has been previously
reported that Cyp1a induction is detected in vascular endothelia,
myocardium and caudal fin of treated fish in whole mount and
section immunostaining [25,36,37]. Nonetheless, GFP expression
in the blood vessels, heart muscles and caudal fin was rather weak
in comparison to the intense GFP signal in the major organs such
as liver, kidney and gut (Figure 2C); thus, whole mount in situ
hybridization is unable to detect the low level of expression.
We also noticed a trend that an increasing number of organs
express GFP with increasing TCDD concentration. The order of
these organs expressing GFP from low to high concentrations of
TCDD is as follows: Kidney and liver.Gut.olfactory pits and
caudal fin.gills.neuromast cells (Figure 1). Although the
phenotypic expression was difficult to quantify with concentration,
the order of organs that expressed GFP can be a rough indicator of
relative dosage of TCDD.
Tg(cyp1a:gfp) medaka for biomonitoring assays
We have tested Tg(cyp1a:gfp) medaka with TCDD at three
different development stages: pre-hatching embryos, post-hatching
fry and adult. In all the three stages, GFP was induced within
24 hours of TCDD exposure. However, the induced GFP
expression in early embryos was relatively weak compared to the
post-hatching fry and adults. This is likely due to both of the
presence of thick chorion in pre-hatching embryos, which may
affect the permeability of chemicals, and the weak AhR activity
before the metabolic organs become mature. Consistent with this,
we did observe stronger GFP expression induced by TCDD in the
kidney, liver and gut at 3 dpf when these organs begin to develop
(stage 19–26) [17]. Although strong GFP expression was observed
in the kidney and olfactory pits in the adult transgenic fish after
24 hours of exposure, due to the presence of the thick body wall,
GFP expression within abdomen area could not be sensitively
observed unless dissected. This problem could be overcome by
inserting the cyp1a:gfp construct in the see-through medaka strain
[38], which remains transparent in both embryonic and adult
stages, thus allowing fluorescence in internal organs to be observed
directly without a need to sacrifice the animal. Currently, larvae
stage remains the best stage for biomonitoring due to its complete
and functional organs development and also the ease of detection
in its transparent body at this stage.
Based on the data presented here, it is feasible to develop two
biomonitoring systems using the Tg(cyp1a:gfp) medaka. One is to
use the newly hatched fry as they offer maximal sensitivity to
TCDD induction and the assay can be performed for at least
72 hours without feeding since the newly hatched fry can rely on
their yolk reserve in the first few days after hatching. The assay can
be used for large scale of chemical screening for xenobiotic activity
because of the easy availability of a large number of fry. Another
assay is based on the adult and it can be developed into both
laboratory-based and on-site monitoring systems for both acute
and chronic exposure. For on-site monitoring, medaka offer
additional advantages as medaka fish are very hardy and can
adapt in a broad salinity (up to 50% sea water) and a wide range of
temperature from near 4uC to 40uC [15,39]. Thus, Tg(cyp1a:gfp)
transgenic medaka can be used in broad environmental conditions
compared to most other fish species including the popular
zebrafish model.
Supporting Information
Figure S1 Whole mount in situ hybridization with cyp1a
sense probe in newly hatched fry in 0.1% DMSO vehicle
solvent control (A) or 5 nM TCDD (B).
(PDF)
Figure S2 Weak GFP induction by Tg(cyp1a:gfp) fry by
4-nitrophenol. (A) Lack of detectable GFP expression in a fry in
the control (egg water) group. (B) Spotty GFP expression in the
liver from a fry in the 4-nitrophenol treatment group. (C)
Percentages of fry expressing GFP in the liver induced by 4-
nitrophenol. Abbreviation: lv, liver.
(PDF)
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Figure S3 Transient and consitutive GFP expression in
the mid-brain of Tg(cyp1a:gfp) embryos at 1 dpf. (A)
Brightfield view. (B) Fluorescent view. (C) Merged view. The GFP
signal is diminished by 2 dpf. White arrowheads point to the
positions of GFP expression and astrisks denote eyes.
(PDF)
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